
INmune Bio INMB
€ 2.16
2.87%
INmune Bio Kurzfristige Verbindlichkeiten | INMB
Kurzfristige Verbindlichkeiten Jährlich INmune Bio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.42 M | 7.22 M | 18.5 M | 10.9 M | 4.36 M | 1.78 M | 700 K | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 18.5 M | 700 K | 7.41 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Фармсинтез
LIFE
|
1.02 B | - | - | - | ||
|
Ayala Pharmaceuticals
AYLA
|
7.54 M | - | - | $ 7.46 M | ||
|
Revolution Medicines
RVMD
|
290 M | $ 207.32 | 0.24 % | $ 39.4 B | ||
|
Rhythm Pharmaceuticals
RYTM
|
106 M | $ 101.8 | 0.08 % | $ 6.62 B | ||
|
Rezolute
RZLT
|
11.9 M | $ 4.4 | 0.88 % | $ 334 M | ||
|
Sana Biotechnology
SANA
|
78.7 M | $ 3.45 | 0.77 % | $ 874 M | ||
|
Seer
SEER
|
15.7 M | $ 1.95 | 0.26 % | $ 108 M | ||
|
Precigen
PGEN
|
37.3 M | $ 6.87 | 0.14 % | $ 2.15 B | ||
|
SIGA Technologies
SIGA
|
18 M | $ 3.2 | 1.86 % | $ 229 M | ||
|
Syndax Pharmaceuticals
SNDX
|
120 M | $ 19.94 | 0.05 % | $ 1.73 B | ||
|
Soligenix
SNGX
|
3.7 M | $ 0.38 | 1.18 % | $ 1.97 M | ||
|
Spruce Biosciences
SPRB
|
10.1 M | $ 59.09 | 2.0 % | $ 45.3 M | ||
|
Sarepta Therapeutics
SRPT
|
1.1 B | $ 20.94 | 0.04 % | $ 2.1 B | ||
|
Stoke Therapeutics
STOK
|
57.9 M | $ 30.05 | 0.81 % | $ 1.78 B | ||
|
Sutro Biopharma
STRO
|
75.1 M | $ 19.1 | 0.34 % | $ 162 M | ||
|
Shattuck Labs
STTK
|
7.05 M | $ 6.5 | 0.29 % | $ 452 M | ||
|
Supernus Pharmaceuticals
SUPN
|
338 M | $ 42.43 | 0.23 % | $ 2.4 B | ||
|
Savara
SVRA
|
20.4 M | $ 5.53 | 2.98 % | $ 1.23 B | ||
|
China SXT Pharmaceuticals
SXTC
|
4.35 M | $ 2.24 | 0.45 % | $ 1.52 M | ||
|
Bio-Techne Corporation
TECH
|
164 M | $ 72.31 | 0.01 % | $ 11.3 B | ||
|
Tenax Therapeutics
TENX
|
7.16 M | $ 1.98 | 2.06 % | $ 77.7 M | ||
|
Teva Pharmaceutical Industries Limited
TEVA
|
13.5 B | $ 36.76 | 1.21 % | $ 42.1 B | ||
|
TG Therapeutics
TGTX
|
154 M | $ 55.74 | 0.58 % | $ 8.04 B | ||
|
Trevi Therapeutics
TRVI
|
9.75 M | $ 16.82 | 1.17 % | $ 2.27 B | ||
|
Taysha Gene Therapies
TSHA
|
26.6 M | $ 5.48 | 0.54 % | $ 1.75 B | ||
|
Sol-Gel Technologies Ltd.
SLGL
|
6.17 M | $ 69.37 | 0.35 % | $ 193 M | ||
|
UroGen Pharma Ltd.
URGN
|
46.4 M | $ 43.82 | 0.02 % | $ 2.11 B | ||
|
United Therapeutics Corporation
UTHR
|
561 M | $ 497.97 | 2.12 % | $ 22.1 B | ||
|
Spero Therapeutics
SPRO
|
8.87 M | $ 1.19 | 0.41 % | $ 66.7 M | ||
|
Scholar Rock Holding Corporation
SRRK
|
55.4 M | $ 57.42 | 3.78 % | $ 6.59 B | ||
|
Jounce Therapeutics
JNCE
|
23.6 M | - | - | $ 98.4 M | ||
|
NextCure
NXTC
|
10.6 M | $ 8.42 | 7.67 % | $ 23.9 M | ||
|
Verrica Pharmaceuticals
VRCA
|
16.4 M | $ 5.26 | 0.75 % | $ 56 M | ||
|
Viridian Therapeutics
VRDN
|
70.7 M | $ 23.17 | 1.09 % | $ 2.36 B | ||
|
Zosano Pharma Corporation
ZSAN
|
11.1 M | - | 7.23 % | $ 2.72 M | ||
|
Vertex Pharmaceuticals Incorporated
VRTX
|
3.86 B | $ 528.9 | 0.22 % | $ 135 B | ||
|
Verastem
VSTM
|
72.3 M | $ 8.08 | 0.55 % | $ 560 M | ||
|
vTv Therapeutics
VTVT
|
6.64 M | $ 32.79 | 0.03 % | $ 130 M | ||
|
Voyager Therapeutics
VYGR
|
26.5 M | $ 3.4 | 3.85 % | $ 200 M | ||
|
Aravive
ARAV
|
22.1 M | - | -13.39 % | $ 1.45 M | ||
|
Wave Life Sciences Ltd.
WVE
|
95.1 M | $ 4.91 | 1.03 % | $ 828 M | ||
|
Tonix Pharmaceuticals Holding Corp.
TNXP
|
30.8 M | $ 13.16 | 0.15 % | $ 112 M | ||
|
Xenetic Biosciences
XBIO
|
968 K | $ 4.28 | 0.86 % | $ 7.28 M | ||
|
XBiotech
XBIT
|
7.93 M | $ 2.18 | 0.23 % | $ 66.5 M | ||
|
Exicure
XCUR
|
3.89 M | $ 1.41 | 12.8 % | $ 8.88 M | ||
|
Xenon Pharmaceuticals
XENE
|
41.8 M | $ 59.55 | 0.18 % | $ 4.72 B | ||
|
Xeris Pharmaceuticals
XERS
|
110 M | $ 8.48 | 0.12 % | $ 1.36 B |